Stocks and Investing Stocks and Investing
Tue, May 31, 2022
Mon, May 30, 2022
Fri, May 27, 2022

Andrew Berens Maintained (ZYME) at Buy with Increased Target to $19 on, May 27th, 2022


Published on 2024-10-27 21:20:48 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Leerink, Maintained "Zymeworks Inc." (ZYME) at Buy with Increased Target from $18 to $19 on, May 27th, 2022.

Andrew has made no other calls on ZYME in the last 4 months.



There are 5 other peers that have a rating on ZYME. Out of the 5 peers that are also analyzing ZYME, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Andrew


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $40 on, Monday, May 23rd, 2022
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $28 on, Monday, May 9th, 2022
  • Charles Zhu of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $14 on, Thursday, May 5th, 2022
  • Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $15 on, Tuesday, March 15th, 2022
  • Jim Birchenough of "Wells Fargo" Maintained at Buy with Decreased Target to $48 on, Wednesday, February 9th, 2022

Contributing Sources